Efsubaglutide Alfa
Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents
Shanghai Yinnuo Pharmaceutical Technology Co · Phase 1 · Recruiting · Enrollment 36
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Efsubaglutide Alfa 5 mg QW | Obesity or overweight | 5 mg | 12 | n/r | n/r |
| Efsubaglutide Alfa 10 mg QW | Obesity or overweight | 10 mg | 12 | n/r | n/r |
| Efsubaglutide Alfa 20 mg QW | Obesity or overweight | 20 mg | 12 | n/r | n/r |
| Efsubaglutide Alfa placebo | Obesity or overweight | n/r | 12 | n/r | n/r |